To understand the impact of pancreatic cancers on body organs within the context of cancer induced cachexia we have, in ongoing studies, characterized the metabolism of organs in tumor bearing mice. Cancer-induced cachexia occurs in 80% of pancreatic ductal adenocarcinoma (PDAC) patients. Here we present data demonstrating the significant impact of cachexia-inducing Pa04C PDAC xenografts compared to non-cachexia inducing Panc1 xenografts and normal mice on kidney and lung metabolites as identified by 1H MRS of tissue extracts. These metabolic changes may contribute to increased morbidity and poor quality of life but equally may present novel targets for intervention.
This abstract and the presentation materials are available to members only; a login is required.